Angiotensin-converting enzyme inhibitor-associated angioedema.

Abstract excerpt

Angioedema, characterized by swelling of the lips, face, and tongue, occurs in anywhere from 0.1% to 6% of angiotensin-converting enzyme (ACE) inhibitor users. The incidence is more common in black Americans than in white Americans, in women than in men, and in smokers than in nonsmokers. The remitting and relapsing nature of ACE inhibitor-associated angioedema can confound clinical recognition of the adverse...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Angioedema
• Share to Angiotensin-Converting Enzyme Inhibitors
• Share to ACE gene